1225617

Janusz Jaworski, M.D., Ph.D — FEI 3011115378

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 10, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Warsaw (Poland)

Additional Details

Clinical Investigator (CI)